Director – Commercial Project Management
Revolution Medicines
Director – Commercial Project Management
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
This is a unique opportunity to play a critical role in advancing Revolution Medicines' commercialization strategy during a period of significant growth. We are seeking an experienced and highly collaborative Director, Commercial Project Management to lead in one of the company's key Disease Areas by driving cross-functional planning, alignment, and execution across global commercialization priorities.
This role sits within the Commercialization Effectiveness & Operations (CE&O) function and reports to the Executive Director, Global Commercialization Effectiveness.
In partnership with Global Commercial, Medical, Market Access, and cross-functional leaders, you will serve as the primary project management partner to the Global Commercialization Team, the Global Commercial Team and other cross-functional teams in your assigned Disease Area.
Operating in a build-while-scaling environment, you will bring clarity, structure, and execution discipline to complex cross-functional initiatives while helping strengthen commercialization ways of working. As the capability matures, this role may expand to include people leadership responsibilities.
What You’ll Do:
Lead project management support for Global Commercialization Teams and Global Commercial Teams within an assigned Disease Area, driving alignment, accountability, and execution across strategic priorities.
Drive execution of global commercial and commercialization initiatives, ensuring milestones, risks, dependencies, and key decisions are effectively managed.
Coordinate and integrate inputs across Commercial, Medical, Market Access, Regulatory, Supply, Legal, Finance, and regional stakeholders into cohesive commercialization plans.
Facilitate planning, governance, and decision-making processes, ensuring effective follow-through on actions and commitments.
Identify and proactively manage risks, dependencies, and execution challenges, escalating issues as appropriate.
Develop and maintain project plans, dashboards, timelines, and reporting tools that provide visibility into progress and priorities.
to ensure alignment between execution needs, planning processes, and organizational priorities.
Support launch readiness and other key commercialization initiatives within the Disease Area.
Partner closely with Project Management colleagues across the organization to ensure alignment between development, life cycle, medical, market access and commercial plans and deliverables.
Contribute to the development of Commercial Project Management capabilities, including tools, templates, best practices, and ways of working.
Who You Are:
You thrive in complex, cross-functional environments and enjoy bringing structure, clarity, and momentum to challenging initiatives. You are a strong collaborator who can influence across functions and levels of the organization while maintaining focus on outcomes.
You combine project leadership expertise with sound judgment, strong organizational skills, and the ability to translate strategy into actionable plans. You are comfortable navigating ambiguity, balancing competing priorities, and communicating effectively with both working teams and senior leaders.
Required Skills, Experience and Education:
Bachelor’s degree, with 10+ years of relevant experience in biotech/pharma/healthcare.
Significant experience leading complex, cross‑functional projects or commercialization initiatives.
Experience supporting global commercial organizations, including launch readiness, lifecycle management, or major commercialization initiatives.
Experience working across global and regional operating models.
Strong project management skills, including planning, dependency management, risk management, stakeholder leadership, and executive communication.
Proven ability to influence without authority and drive alignment across diverse stakeholder groups.
Experience partnering with senior commercial, medical affairs, market access, and cross-functional leaders.
Track record of thriving in fast-paced, evolving environments with a proactive, solutions-oriented mindset.
Excellent communication, facilitation, and interpersonal skills, with the ability to translate complexity into clarity for diverse audiences.
Strong judgment, organizational skills, and attention to detail.
Preferred Skills:
Advanced degree (MBA/MS/PhD).
Oncology / specialty pharma commercialization experience.
Formal Project Management training or certification (e.g., PMP).
Experience supporting multiple concurrent programs or portfolios.
Early people leadership experience or readiness to step into people leadership as the capability scales.
#LI-TS1 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 201000 - 251000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines